Holger Wesche - 01 Jul 2021 Form 4 Insider Report for Harpoon Therapeutics, Inc.

Role: Chief Scientific Officer
Signature: /s/ Holger Wesche by Christopher Whitmore, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 01 Jul 2021
Net transactions value: -$134,000
Form type: 4
Filing time: 06 Jul 2021, 18:01:43 UTC
Next filing: 15 Nov 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HARP	Common Stock	Options Exercise	$6,000	+10,000	+19%	$0.6000	62,852	01 Jul 2021	Direct
transaction	HARP	Common Stock	Sale	$140,000	-10,000	-16%	$14.00^*	52,852	01 Jul 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HARP	Employee Stock Option (right to buy)	Options Exercise	$0	-10,000	-32%	$0.000000	21,002	01 Jul 2021	Common Stock	10,000	$0.6000	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2	The shares subject to the option are fully vested and exercisable.